Logo image
IRO Home Research units Researcher Profiles
Sign in
Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021
Journal article   Open access   Peer reviewed

Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021

Alexandre R Marra, João Luiz Miraglia, Daniel Tavares Malheiros, Yang Guozhang, Vanessa Damazio Teich, Elivane da Silva Victor, João Renato Rebello Pinho, Adriana Cypriano, Laura Wanderly Vieira, Miria Polonio, …
Clinical infectious diseases, Vol.76(3), pp.e360-e366
02/01/2023
DOI: 10.1093/cid/ciac430
PMCID: PMC9213833
PMID: 35639918
url
https://doi.org/10.1093/cid/ciac430View
Published (Version of record) Open Access

Abstract

The viral vector and inactivated virus COVID-19 vaccines can significantly prevent COVID-19 infection among healthcare workers when boosted with a third dose of Pfizer/BioNTech vaccine. The heterologous booster strategy was effective even after emergence of SARS-CoV-2 variants (Gamma and Delta).
AcademicSubjects BioNTech booster CoronaVac COVID-19 vaccine effectiveness Major MED00290 Oxford-AstraZeneca Pfizer

Details

Logo image